NCT05242640

Brief Summary

The aim of this study is to assess the feasibility and acceptability (e.g., enrollment, adherence, retention, acceptability of procedures and interventions) of a pilot factorial study design that will help elucidate components of mind-body exercise interventions. The study involves completing a walking program, a mindful attention program, a walking program that includes mindful attention, or no program at all. A "pilot" study is a smaller study that helps researchers to understand whether the study design can be carried out and what participants think about the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 27, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

February 16, 2022

Completed
12 months until next milestone

Study Start

First participant enrolled

January 31, 2023

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 9, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 9, 2026

Completed
Last Updated

April 20, 2026

Status Verified

April 1, 2026

Enrollment Period

3.1 years

First QC Date

January 27, 2022

Last Update Submit

April 17, 2026

Conditions

Outcome Measures

Primary Outcomes (8)

  • Feasibility of screening: screened to eligible ratio

    percent of screened individuals that were determined eligible for the study

    Through study completion, an average of 1 year

  • Feasibility of enrollment: eligible to enrollment ratio

    percent of eligible individuals that enroll in the study; determined to be feasible if greater than or equal to 70% of eligible patients enroll

    Through study completion, an average of 1 year

  • Feasibility of retention: retention at each assessment

    percent of enrolled participants retained at post-intervention and 3-month follow-up; determined to be feasible if greater than or equal to 70% retention at each assessment

    6 months

  • Feasibility of interventions: attendance rates for each session

    percent session attendance; determined to be feasible if participants attend greater than or equal to 75% of sessions

    6 months

  • Feasibility of survey completion: survey completion rates at each assessment

    percent of participants that complete surveys at post-intervention and 3-month follow-up

    6 months

  • Acceptability of interventions

    Acceptability of the interventions will be assessed via overall satisfaction (1 = not at all to 10 = very much); determined to be acceptable if mean rating is greater than or equal to 7.5 across 80% of sessions

    6 months

  • Acceptability of study design

    Acceptability of the study design will be assessed via acceptability of study procedures (1= not at all to 10 = very much); determined to be acceptable if mean rating is greater than or equal to 7.5 across 80% of sessions

    6 months

  • Perspectives on study interventions

    Perspectives on study interventions will be assessed via exit interview

    Post-intervention (after 8 week intervention)

Secondary Outcomes (12)

  • Ventilatory efficiency

    Baseline (week 0), post-intervention (after 8 week intervention)

  • Heart rate dynamics

    Baseline (week 0), post-intervention (after 8 week intervention)

  • Positive affect

    Baseline (week 0), post-intervention (after 8 week intervention), 3 months post-intervention

  • Emotion regulation

    Baseline (week 0), post-intervention (after 8 week intervention), 3 months post-intervention

  • Interoceptive awareness

    Baseline (week 0), post-intervention (after 8 week intervention), 3 months post-intervention

  • +7 more secondary outcomes

Study Arms (4)

Mindful attention

EXPERIMENTAL

16 sessions over 8 weeks (2x/week) of mindful attention audio recordings delivered via headphones

Other: Mindful attention

Exercise

EXPERIMENTAL

16 sessions over 8 weeks (2x/week) of moderate-intensity treadmill walking

Other: Exercise

Exercise with mindful attention

EXPERIMENTAL

16 sessions over 8 weeks (2x/week) of moderate-intensity treadmill walking utilizing mindful attention audio recordings delivered via headphones

Other: Exercise with mindful attention

No intervention

NO INTERVENTION

No intervention sessions

Interventions

Participants will complete a moderate-intensity walking program

Exercise

Participants will listen to mindful attention audio recordings via headphones

Mindful attention

Participants will complete a moderate-intensity walking program while listening to mindful attention audio recordings via headphones

Exercise with mindful attention

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Metabolic syndrome, defined as meeting 3 or more of the following criteria in the last 12 months at the time of medical record review: (a) BMI ≥ 25; (b) fasting glucose ≥ 100 \[5.6 mmol/L\] or A1C ≥ 5.7 or medications; (c) blood pressure ≥ 130 systolic or ≥ 85 diastolic or medications; (d) triglycerides ≥ 150 or 1.7 mmol/L or medications; (e) or HDL \< 40mg/ dL for men and 50mg/dL for women or medications;
  • insufficiently active, defined as a score ≤ 23 (moderate-to-strenuous units) on Godin-Shepard Leisure-Time Physical Activity Questionnaire;
  • age 18-70 years;
  • given medical clearance for moderate-intensity exercise and exercise stress testing by their primary care physician (PCP);
  • access to a device with internet and videoconferencing capabilities

You may not qualify if:

  • current diagnosis of any of the following: (a) coronary artery disease or other chronic heart diseases (e.g., heart failure) in which exercise would be contraindicated or that would preclude HRV analyses (e.g., some arrhythmias); (b) any diabetes; (c) chronic obstructive pulmonary disease or other severe lung dysfunction (e.g., severe asthma); (d) severe cognitive impairment
  • \>2 self-reported classes or self-guided mindfulness or mindful movement sessions per week in past 3 months
  • self-reported inability to speak and read in English
  • current beta blocker or calcium channel blocker medication
  • uncontrolled hypertension, defined as resting blood pressure ≥ 150 systolic or ≥ 90 diastolic in the last 6 months
  • self- or physician-reported contraindications for exercise (e.g., severe balance impairment, musculoskeletal restrictions)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States

Location

MeSH Terms

Conditions

Metabolic Syndrome

Interventions

Exercise

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Instructor of Medicine

Study Record Dates

First Submitted

January 27, 2022

First Posted

February 16, 2022

Study Start

January 31, 2023

Primary Completion

March 9, 2026

Study Completion

March 9, 2026

Last Updated

April 20, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations